Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Circulating cathepsin-S levels correlate with GFR decline and sTNFR1 and sTNFR2 levels in mice and humans.

Steubl D, Kumar SV, Tato M, Mulay SR, Larsson A, Lind L, Risérus U, Renders L, Heemann U, Carlsson AC, Ärnlöv J, Anders HJ.

Sci Rep. 2017 Feb 27;7:43538. doi: 10.1038/srep43538.

2.

Soluble tumor necrosis factor receptor 1 is associated with diminished estimated glomerular filtration rate in colombian patients with type 2 diabetes.

Gómez-Banoy N, Cuevas V, Higuita A, Aranzález LH, Mockus I.

J Diabetes Complications. 2016 Jul;30(5):852-7. doi: 10.1016/j.jdiacomp.2016.03.015. Epub 2016 Mar 17.

PMID:
27068267
3.

Soluble tumor necrosis factor receptor 1 (sTNFR1) is associated with increased total mortality due to cancer and cardiovascular causes - findings from two community based cohorts of elderly.

Carlsson AC, Juhlin CC, Larsson TE, Larsson A, Ingelsson E, Sundström J, Lind L, Arnlöv J.

Atherosclerosis. 2014 Nov;237(1):236-42. doi: 10.1016/j.atherosclerosis.2014.09.005. Epub 2014 Sep 16.

PMID:
25255422
4.
5.

Association between levels of pentraxin 3 and incidence of chronic kidney disease in the elderly.

Sjöberg B, Qureshi AR, Heimbürger O, Stenvinkel P, Lind L, Larsson A, Bárány P, Ärnlöv J.

J Intern Med. 2016 Feb;279(2):173-9. doi: 10.1111/joim.12411. Epub 2015 Sep 9.

6.

Association of soluble tumor necrosis factor receptors 1 and 2 with nephropathy, cardiovascular events, and total mortality in type 2 diabetes.

Carlsson AC, Östgren CJ, Nystrom FH, Länne T, Jennersjö P, Larsson A, Ärnlöv J.

Cardiovasc Diabetol. 2016 Feb 29;15:40. doi: 10.1186/s12933-016-0359-8.

7.

Soluble tumor necrosis factor receptor 1 and 2 predict outcomes in advanced chronic kidney disease: a prospective cohort study.

Neirynck N, Glorieux G, Schepers E, Verbeke F, Vanholder R.

PLoS One. 2015 Mar 30;10(3):e0122073. doi: 10.1371/journal.pone.0122073. eCollection 2015.

8.

Soluble TNF receptors and kidney dysfunction in the elderly.

Carlsson AC, Larsson TE, Helmersson-Karlqvist J, Larsson A, Lind L, Ärnlöv J.

J Am Soc Nephrol. 2014 Jun;25(6):1313-20. doi: 10.1681/ASN.2013080860. Epub 2014 Feb 7.

9.

Plasma concentrations of TNF-alpha and its soluble receptors sTNFR1 and sTNFR2 in patients with coronary artery disease.

Safranow K, Dziedziejko V, Rzeuski R, Czyzycka E, Wojtarowicz A, Bińczak-Kuleta A, Jakubowska K, Olszewska M, Ciechanowicz A, Kornacewicz-Jach Z, Machaliński B, Pawlik A, Chlubek D.

Tissue Antigens. 2009 Nov;74(5):386-92. doi: 10.1111/j.1399-0039.2009.01332.x.

PMID:
19845893
10.

Association between serum soluble TNFα receptors and renal dysfunction in type 2 diabetic patients without proteinuria.

Miyazawa I, Araki S, Obata T, Yoshizaki T, Morino K, Kadota A, Ugi S, Kawai H, Uzu T, Nishio Y, Koya D, Haneda M, Kashiwagi A, Maegawa H.

Diabetes Res Clin Pract. 2011 May;92(2):174-80. doi: 10.1016/j.diabres.2011.01.008. Epub 2011 Feb 1.

PMID:
21288590
11.

Soluble tumor necrosis factor receptors are associated with severity of kidney dysfunction in pediatric chronic kidney disease.

Moreira JM, da Silva AN, Marciano Vieira ÉL, Teixeira AL, Kummer AM, Simões E Silva AC.

Pediatr Nephrol. 2019 Feb;34(2):349-352. doi: 10.1007/s00467-018-4124-y. Epub 2018 Oct 29.

PMID:
30374604
12.

Soluble Tumor Necrosis Factor Receptor 1 Is Associated with Glomerular Filtration Rate Progression and Incidence of Chronic Kidney Disease in Two Community-Based Cohorts of Elderly Individuals.

Carlsson AC, Nordquist L, Larsson TE, Carrero JJ, Larsson A, Lind L, Ärnlöv J.

Cardiorenal Med. 2015 Oct;5(4):278-88. doi: 10.1159/000435863. Epub 2015 Jul 31.

13.

TNF-α and soluble forms of TNF receptors 1 and 2 in the serum of patients with Crohn's disease and ulcerative colitis.

Owczarek D, Cibor D, Głowacki MK, Cieśla A, Mach P.

Pol Arch Med Wewn. 2012;122(12):616-23. Epub 2012 Nov 18.

14.

Endostatin level is associated with kidney injury in the elderly: findings from two community-based cohorts.

Ruge T, Carlsson AC, Larsson TE, Carrero JJ, Larsson A, Lind L, Ärnlöv J.

Am J Nephrol. 2014;40(5):417-24. doi: 10.1159/000369076. Epub 2014 Nov 14.

PMID:
25401956
15.

Association of TNF Receptor 2 and CRP with GFR Decline in the General Nondiabetic Population.

Schei J, Stefansson VT, Eriksen BO, Jenssen TG, Solbu MD, Wilsgaard T, Melsom T.

Clin J Am Soc Nephrol. 2017 Apr 3;12(4):624-634. doi: 10.2215/CJN.09280916. Epub 2017 Feb 2.

16.

Residual Associations of Inflammatory Markers with eGFR after Accounting for Measured GFR in a Community-Based Cohort without CKD.

Schei J, Stefansson VT, Mathisen UD, Eriksen BO, Solbu MD, Jenssen TG, Melsom T.

Clin J Am Soc Nephrol. 2016 Feb 5;11(2):280-6. doi: 10.2215/CJN.07360715. Epub 2015 Dec 14.

17.

Association of Soluble TNFR-1 Concentrations with Long-Term Decline in Kidney Function: The Multi-Ethnic Study of Atherosclerosis.

Bhatraju PK, Zelnick LR, Shlipak M, Katz R, Kestenbaum B.

J Am Soc Nephrol. 2018 Nov;29(11):2713-2721. doi: 10.1681/ASN.2018070719. Epub 2018 Oct 4.

18.

Structural damage in diabetic nephropathy is associated with TNF-α system activity.

Fernández-Real JM, Vendrell J, García I, Ricart W, Vallès M.

Acta Diabetol. 2012 Aug;49(4):301-5. doi: 10.1007/s00592-011-0349-y. Epub 2011 Nov 1.

PMID:
22042131
19.

Use of Proteomics To Investigate Kidney Function Decline over 5 Years.

Carlsson AC, Ingelsson E, Sundström J, Carrero JJ, Gustafsson S, Feldreich T, Stenemo M, Larsson A, Lind L, Ärnlöv J.

Clin J Am Soc Nephrol. 2017 Aug 7;12(8):1226-1235. doi: 10.2215/CJN.08780816. Epub 2017 Jul 21.

20.

Tumor necrosis factor-alpha and soluble TNF-alpha receptor responses in young vs. middle-aged males following eccentric exercise.

Arroyo E, Wells AJ, Gordon JA 3rd, Varanoske AN, Gepner Y, Coker NA, Church DD, Fukuda DH, Stout JR, Hoffman JR.

Exp Gerontol. 2017 Dec 15;100:28-35. doi: 10.1016/j.exger.2017.10.012. Epub 2017 Oct 14.

PMID:
29038027

Supplemental Content

Support Center